Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells.

Zhou Y, Chung PY, Ma JY, Lam AK, Law S, Chan KW, Chan AS, Li X, Lam KH, Chui CH, Tang JC.

Biology (Basel). 2019 Oct 1;8(4). pii: E75. doi: 10.3390/biology8040075.

2.

Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma.

Chung PY, Lam PL, Zhou YY, Gasparello J, Finotti A, Chilin A, Marzaro G, Gambari R, Bian ZX, Kwok WM, Wong WY, Wang X, Lam AK, Chan AS, Li X, Ma JY, Chui CH, Lam KH, Tang JC.

Cells. 2018 Oct 22;7(10). pii: E177. doi: 10.3390/cells7100177.

3.

Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE2.

Pun IH, Chan D, Chan SH, Chung PY, Zhou YY, Law S, Lam AK, Chui CH, Chan AS, Lam KH, Tang JC.

Cancer Res Treat. 2017 Jan;49(1):219-229. doi: 10.4143/crt.2016.190. Epub 2016 Jul 18.

4.

Recent advances in research of natural and synthetic bioactive quinolines.

Chung PY, Bian ZX, Pun HY, Chan D, Chan AS, Chui CH, Tang JC, Lam KH.

Future Med Chem. 2015;7(7):947-67. doi: 10.4155/fmc.15.34. Review.

PMID:
26061110

Supplemental Content

Loading ...
Support Center